Pricing updated 2019-07-17. Prices are subject to change without notice.
A number of tumor cells and cell lines have been observed to have highly upregulated expression and activity of fatty acid synthase (FASN). GSK837149A is a selective, reversible inhibitor of FASN (pIC50 = 7.8).1 It acts by inhibiting the β-ketoacyl reductase activity of FASN.
Warning - this product is not for human or veterinary use.
View the Cayman Structure Database for chemical structure definitions for many Cayman products
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data pack, and GC-MS data.
Vázquez, M.J., Leavens, W., Liu, R., et al. Discovery of GSK837149A, an inhibitor of human fatty acid synthase targeting the β-